Global Gene Engineered Subunit Vaccine Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
A gene engineered subunit vaccine or a bio-recombinant subunit vaccine refers to the expression of a protective antigen gene in a prokaryotic or eukaryotic cell, and a vaccine made from a gene product—protein or polypeptide.
LPI (LP Information)' newest research report, the “Gene Engineered Subunit Vaccine Industry Forecast” looks at past sales and reviews total world Gene Engineered Subunit Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Engineered Subunit Vaccine sales for 2023 through 2029. With Gene Engineered Subunit Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Engineered Subunit Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Gene Engineered Subunit Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Engineered Subunit Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Engineered Subunit Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Engineered Subunit Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Engineered Subunit Vaccine.
The global Gene Engineered Subunit Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene Engineered Subunit Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene Engineered Subunit Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene Engineered Subunit Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene Engineered Subunit Vaccine players cover Merck, GSK, Tiantan, Pulike, Greffex, CureVac, Yebio, Sanofi Pasteur SA and Virbac, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Engineered Subunit Vaccine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
A gene engineered subunit vaccine or a bio-recombinant subunit vaccine refers to the expression of a protective antigen gene in a prokaryotic or eukaryotic cell, and a vaccine made from a gene product—protein or polypeptide.
LPI (LP Information)' newest research report, the “Gene Engineered Subunit Vaccine Industry Forecast” looks at past sales and reviews total world Gene Engineered Subunit Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Engineered Subunit Vaccine sales for 2023 through 2029. With Gene Engineered Subunit Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Engineered Subunit Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Gene Engineered Subunit Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Engineered Subunit Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Engineered Subunit Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Engineered Subunit Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Engineered Subunit Vaccine.
The global Gene Engineered Subunit Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene Engineered Subunit Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene Engineered Subunit Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene Engineered Subunit Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene Engineered Subunit Vaccine players cover Merck, GSK, Tiantan, Pulike, Greffex, CureVac, Yebio, Sanofi Pasteur SA and Virbac, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Engineered Subunit Vaccine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Therapeutic Gene Engineered Subunit Vaccine
- Preventative Gene Engineered Subunit Vaccine
- Human Use
- Veterinary Use
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- GSK
- Tiantan
- Pulike
- Greffex
- CureVac
- Yebio
- Sanofi Pasteur SA
- Virbac
- Pfizer Inc.
- Walvax Biotechnology
- Kontec
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Engineered Subunit Vaccine Market Size 2018-2029
2.1.2 Gene Engineered Subunit Vaccine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene Engineered Subunit Vaccine Segment by Type
2.2.1 Therapeutic Gene Engineered Subunit Vaccine
2.2.2 Preventative Gene Engineered Subunit Vaccine
2.3 Gene Engineered Subunit Vaccine Market Size by Type
2.3.1 Gene Engineered Subunit Vaccine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
2.4 Gene Engineered Subunit Vaccine Segment by Application
2.4.1 Human Use
2.4.2 Veterinary Use
2.5 Gene Engineered Subunit Vaccine Market Size by Application
2.5.1 Gene Engineered Subunit Vaccine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
3 GENE ENGINEERED SUBUNIT VACCINE MARKET SIZE BY PLAYER
3.1 Gene Engineered Subunit Vaccine Market Size Market Share by Players
3.1.1 Global Gene Engineered Subunit Vaccine Revenue by Players (2018-2023)
3.1.2 Global Gene Engineered Subunit Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Gene Engineered Subunit Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE ENGINEERED SUBUNIT VACCINE BY REGIONS
4.1 Gene Engineered Subunit Vaccine Market Size by Regions (2018-2023)
4.2 Americas Gene Engineered Subunit Vaccine Market Size Growth (2018-2023)
4.3 APAC Gene Engineered Subunit Vaccine Market Size Growth (2018-2023)
4.4 Europe Gene Engineered Subunit Vaccine Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene Engineered Subunit Vaccine Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene Engineered Subunit Vaccine Market Size by Country (2018-2023)
5.2 Americas Gene Engineered Subunit Vaccine Market Size by Type (2018-2023)
5.3 Americas Gene Engineered Subunit Vaccine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Engineered Subunit Vaccine Market Size by Region (2018-2023)
6.2 APAC Gene Engineered Subunit Vaccine Market Size by Type (2018-2023)
6.3 APAC Gene Engineered Subunit Vaccine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Engineered Subunit Vaccine by Country (2018-2023)
7.2 Europe Gene Engineered Subunit Vaccine Market Size by Type (2018-2023)
7.3 Europe Gene Engineered Subunit Vaccine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Engineered Subunit Vaccine by Region (2018-2023)
8.2 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE ENGINEERED SUBUNIT VACCINE MARKET FORECAST
10.1 Global Gene Engineered Subunit Vaccine Forecast by Regions (2024-2029)
10.1.1 Global Gene Engineered Subunit Vaccine Forecast by Regions (2024-2029)
10.1.2 Americas Gene Engineered Subunit Vaccine Forecast
10.1.3 APAC Gene Engineered Subunit Vaccine Forecast
10.1.4 Europe Gene Engineered Subunit Vaccine Forecast
10.1.5 Middle East & Africa Gene Engineered Subunit Vaccine Forecast
10.2 Americas Gene Engineered Subunit Vaccine Forecast by Country (2024-2029)
10.2.1 United States Gene Engineered Subunit Vaccine Market Forecast
10.2.2 Canada Gene Engineered Subunit Vaccine Market Forecast
10.2.3 Mexico Gene Engineered Subunit Vaccine Market Forecast
10.2.4 Brazil Gene Engineered Subunit Vaccine Market Forecast
10.3 APAC Gene Engineered Subunit Vaccine Forecast by Region (2024-2029)
10.3.1 China Gene Engineered Subunit Vaccine Market Forecast
10.3.2 Japan Gene Engineered Subunit Vaccine Market Forecast
10.3.3 Korea Gene Engineered Subunit Vaccine Market Forecast
10.3.4 Southeast Asia Gene Engineered Subunit Vaccine Market Forecast
10.3.5 India Gene Engineered Subunit Vaccine Market Forecast
10.3.6 Australia Gene Engineered Subunit Vaccine Market Forecast
10.4 Europe Gene Engineered Subunit Vaccine Forecast by Country (2024-2029)
10.4.1 Germany Gene Engineered Subunit Vaccine Market Forecast
10.4.2 France Gene Engineered Subunit Vaccine Market Forecast
10.4.3 UK Gene Engineered Subunit Vaccine Market Forecast
10.4.4 Italy Gene Engineered Subunit Vaccine Market Forecast
10.4.5 Russia Gene Engineered Subunit Vaccine Market Forecast
10.5 Middle East & Africa Gene Engineered Subunit Vaccine Forecast by Region (2024-2029)
10.5.1 Egypt Gene Engineered Subunit Vaccine Market Forecast
10.5.2 South Africa Gene Engineered Subunit Vaccine Market Forecast
10.5.3 Israel Gene Engineered Subunit Vaccine Market Forecast
10.5.4 Turkey Gene Engineered Subunit Vaccine Market Forecast
10.5.5 GCC Countries Gene Engineered Subunit Vaccine Market Forecast
10.6 Global Gene Engineered Subunit Vaccine Forecast by Type (2024-2029)
10.7 Global Gene Engineered Subunit Vaccine Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Gene Engineered Subunit Vaccine Product Offered
11.1.3 Merck Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Gene Engineered Subunit Vaccine Product Offered
11.2.3 GSK Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 GSK Main Business Overview
11.2.5 GSK Latest Developments
11.3 Tiantan
11.3.1 Tiantan Company Information
11.3.2 Tiantan Gene Engineered Subunit Vaccine Product Offered
11.3.3 Tiantan Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Tiantan Main Business Overview
11.3.5 Tiantan Latest Developments
11.4 Pulike
11.4.1 Pulike Company Information
11.4.2 Pulike Gene Engineered Subunit Vaccine Product Offered
11.4.3 Pulike Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Pulike Main Business Overview
11.4.5 Pulike Latest Developments
11.5 Greffex
11.5.1 Greffex Company Information
11.5.2 Greffex Gene Engineered Subunit Vaccine Product Offered
11.5.3 Greffex Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Greffex Main Business Overview
11.5.5 Greffex Latest Developments
11.6 CureVac
11.6.1 CureVac Company Information
11.6.2 CureVac Gene Engineered Subunit Vaccine Product Offered
11.6.3 CureVac Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 CureVac Main Business Overview
11.6.5 CureVac Latest Developments
11.7 Yebio
11.7.1 Yebio Company Information
11.7.2 Yebio Gene Engineered Subunit Vaccine Product Offered
11.7.3 Yebio Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Yebio Main Business Overview
11.7.5 Yebio Latest Developments
11.8 Sanofi Pasteur SA
11.8.1 Sanofi Pasteur SA Company Information
11.8.2 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product Offered
11.8.3 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Sanofi Pasteur SA Main Business Overview
11.8.5 Sanofi Pasteur SA Latest Developments
11.9 Virbac
11.9.1 Virbac Company Information
11.9.2 Virbac Gene Engineered Subunit Vaccine Product Offered
11.9.3 Virbac Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Virbac Main Business Overview
11.9.5 Virbac Latest Developments
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Company Information
11.10.2 Pfizer Inc. Gene Engineered Subunit Vaccine Product Offered
11.10.3 Pfizer Inc. Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Pfizer Inc. Main Business Overview
11.10.5 Pfizer Inc. Latest Developments
11.11 Walvax Biotechnology
11.11.1 Walvax Biotechnology Company Information
11.11.2 Walvax Biotechnology Gene Engineered Subunit Vaccine Product Offered
11.11.3 Walvax Biotechnology Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Walvax Biotechnology Main Business Overview
11.11.5 Walvax Biotechnology Latest Developments
11.12 Kontec
11.12.1 Kontec Company Information
11.12.2 Kontec Gene Engineered Subunit Vaccine Product Offered
11.12.3 Kontec Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Kontec Main Business Overview
11.12.5 Kontec Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Engineered Subunit Vaccine Market Size 2018-2029
2.1.2 Gene Engineered Subunit Vaccine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene Engineered Subunit Vaccine Segment by Type
2.2.1 Therapeutic Gene Engineered Subunit Vaccine
2.2.2 Preventative Gene Engineered Subunit Vaccine
2.3 Gene Engineered Subunit Vaccine Market Size by Type
2.3.1 Gene Engineered Subunit Vaccine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
2.4 Gene Engineered Subunit Vaccine Segment by Application
2.4.1 Human Use
2.4.2 Veterinary Use
2.5 Gene Engineered Subunit Vaccine Market Size by Application
2.5.1 Gene Engineered Subunit Vaccine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
3 GENE ENGINEERED SUBUNIT VACCINE MARKET SIZE BY PLAYER
3.1 Gene Engineered Subunit Vaccine Market Size Market Share by Players
3.1.1 Global Gene Engineered Subunit Vaccine Revenue by Players (2018-2023)
3.1.2 Global Gene Engineered Subunit Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Gene Engineered Subunit Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE ENGINEERED SUBUNIT VACCINE BY REGIONS
4.1 Gene Engineered Subunit Vaccine Market Size by Regions (2018-2023)
4.2 Americas Gene Engineered Subunit Vaccine Market Size Growth (2018-2023)
4.3 APAC Gene Engineered Subunit Vaccine Market Size Growth (2018-2023)
4.4 Europe Gene Engineered Subunit Vaccine Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene Engineered Subunit Vaccine Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene Engineered Subunit Vaccine Market Size by Country (2018-2023)
5.2 Americas Gene Engineered Subunit Vaccine Market Size by Type (2018-2023)
5.3 Americas Gene Engineered Subunit Vaccine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Engineered Subunit Vaccine Market Size by Region (2018-2023)
6.2 APAC Gene Engineered Subunit Vaccine Market Size by Type (2018-2023)
6.3 APAC Gene Engineered Subunit Vaccine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Engineered Subunit Vaccine by Country (2018-2023)
7.2 Europe Gene Engineered Subunit Vaccine Market Size by Type (2018-2023)
7.3 Europe Gene Engineered Subunit Vaccine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Engineered Subunit Vaccine by Region (2018-2023)
8.2 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE ENGINEERED SUBUNIT VACCINE MARKET FORECAST
10.1 Global Gene Engineered Subunit Vaccine Forecast by Regions (2024-2029)
10.1.1 Global Gene Engineered Subunit Vaccine Forecast by Regions (2024-2029)
10.1.2 Americas Gene Engineered Subunit Vaccine Forecast
10.1.3 APAC Gene Engineered Subunit Vaccine Forecast
10.1.4 Europe Gene Engineered Subunit Vaccine Forecast
10.1.5 Middle East & Africa Gene Engineered Subunit Vaccine Forecast
10.2 Americas Gene Engineered Subunit Vaccine Forecast by Country (2024-2029)
10.2.1 United States Gene Engineered Subunit Vaccine Market Forecast
10.2.2 Canada Gene Engineered Subunit Vaccine Market Forecast
10.2.3 Mexico Gene Engineered Subunit Vaccine Market Forecast
10.2.4 Brazil Gene Engineered Subunit Vaccine Market Forecast
10.3 APAC Gene Engineered Subunit Vaccine Forecast by Region (2024-2029)
10.3.1 China Gene Engineered Subunit Vaccine Market Forecast
10.3.2 Japan Gene Engineered Subunit Vaccine Market Forecast
10.3.3 Korea Gene Engineered Subunit Vaccine Market Forecast
10.3.4 Southeast Asia Gene Engineered Subunit Vaccine Market Forecast
10.3.5 India Gene Engineered Subunit Vaccine Market Forecast
10.3.6 Australia Gene Engineered Subunit Vaccine Market Forecast
10.4 Europe Gene Engineered Subunit Vaccine Forecast by Country (2024-2029)
10.4.1 Germany Gene Engineered Subunit Vaccine Market Forecast
10.4.2 France Gene Engineered Subunit Vaccine Market Forecast
10.4.3 UK Gene Engineered Subunit Vaccine Market Forecast
10.4.4 Italy Gene Engineered Subunit Vaccine Market Forecast
10.4.5 Russia Gene Engineered Subunit Vaccine Market Forecast
10.5 Middle East & Africa Gene Engineered Subunit Vaccine Forecast by Region (2024-2029)
10.5.1 Egypt Gene Engineered Subunit Vaccine Market Forecast
10.5.2 South Africa Gene Engineered Subunit Vaccine Market Forecast
10.5.3 Israel Gene Engineered Subunit Vaccine Market Forecast
10.5.4 Turkey Gene Engineered Subunit Vaccine Market Forecast
10.5.5 GCC Countries Gene Engineered Subunit Vaccine Market Forecast
10.6 Global Gene Engineered Subunit Vaccine Forecast by Type (2024-2029)
10.7 Global Gene Engineered Subunit Vaccine Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Gene Engineered Subunit Vaccine Product Offered
11.1.3 Merck Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Gene Engineered Subunit Vaccine Product Offered
11.2.3 GSK Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 GSK Main Business Overview
11.2.5 GSK Latest Developments
11.3 Tiantan
11.3.1 Tiantan Company Information
11.3.2 Tiantan Gene Engineered Subunit Vaccine Product Offered
11.3.3 Tiantan Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Tiantan Main Business Overview
11.3.5 Tiantan Latest Developments
11.4 Pulike
11.4.1 Pulike Company Information
11.4.2 Pulike Gene Engineered Subunit Vaccine Product Offered
11.4.3 Pulike Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Pulike Main Business Overview
11.4.5 Pulike Latest Developments
11.5 Greffex
11.5.1 Greffex Company Information
11.5.2 Greffex Gene Engineered Subunit Vaccine Product Offered
11.5.3 Greffex Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Greffex Main Business Overview
11.5.5 Greffex Latest Developments
11.6 CureVac
11.6.1 CureVac Company Information
11.6.2 CureVac Gene Engineered Subunit Vaccine Product Offered
11.6.3 CureVac Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 CureVac Main Business Overview
11.6.5 CureVac Latest Developments
11.7 Yebio
11.7.1 Yebio Company Information
11.7.2 Yebio Gene Engineered Subunit Vaccine Product Offered
11.7.3 Yebio Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Yebio Main Business Overview
11.7.5 Yebio Latest Developments
11.8 Sanofi Pasteur SA
11.8.1 Sanofi Pasteur SA Company Information
11.8.2 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product Offered
11.8.3 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Sanofi Pasteur SA Main Business Overview
11.8.5 Sanofi Pasteur SA Latest Developments
11.9 Virbac
11.9.1 Virbac Company Information
11.9.2 Virbac Gene Engineered Subunit Vaccine Product Offered
11.9.3 Virbac Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Virbac Main Business Overview
11.9.5 Virbac Latest Developments
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Company Information
11.10.2 Pfizer Inc. Gene Engineered Subunit Vaccine Product Offered
11.10.3 Pfizer Inc. Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Pfizer Inc. Main Business Overview
11.10.5 Pfizer Inc. Latest Developments
11.11 Walvax Biotechnology
11.11.1 Walvax Biotechnology Company Information
11.11.2 Walvax Biotechnology Gene Engineered Subunit Vaccine Product Offered
11.11.3 Walvax Biotechnology Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Walvax Biotechnology Main Business Overview
11.11.5 Walvax Biotechnology Latest Developments
11.12 Kontec
11.12.1 Kontec Company Information
11.12.2 Kontec Gene Engineered Subunit Vaccine Product Offered
11.12.3 Kontec Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Kontec Main Business Overview
11.12.5 Kontec Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Engineered Subunit Vaccine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Therapeutic Gene Engineered Subunit Vaccine
Table 3. Major Players of Preventative Gene Engineered Subunit Vaccine
Table 4. Gene Engineered Subunit Vaccine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene Engineered Subunit Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
Table 7. Gene Engineered Subunit Vaccine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene Engineered Subunit Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
Table 10. Global Gene Engineered Subunit Vaccine Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene Engineered Subunit Vaccine Revenue Market Share by Player (2018-2023)
Table 12. Gene Engineered Subunit Vaccine Key Players Head office and Products Offered
Table 13. Gene Engineered Subunit Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene Engineered Subunit Vaccine Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene Engineered Subunit Vaccine Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene Engineered Subunit Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene Engineered Subunit Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene Engineered Subunit Vaccine Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene Engineered Subunit Vaccine Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene Engineered Subunit Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene Engineered Subunit Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene Engineered Subunit Vaccine Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene Engineered Subunit Vaccine Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene Engineered Subunit Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene Engineered Subunit Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene Engineered Subunit Vaccine Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene Engineered Subunit Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene Engineered Subunit Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene Engineered Subunit Vaccine Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene Engineered Subunit Vaccine
Table 45. Key Market Challenges & Risks of Gene Engineered Subunit Vaccine
Table 46. Key Industry Trends of Gene Engineered Subunit Vaccine
Table 47. Global Gene Engineered Subunit Vaccine Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene Engineered Subunit Vaccine Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene Engineered Subunit Vaccine Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene Engineered Subunit Vaccine Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Merck Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 52. Merck Gene Engineered Subunit Vaccine Product Offered
Table 53. Merck Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Merck Main Business
Table 55. Merck Latest Developments
Table 56. GSK Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 57. GSK Gene Engineered Subunit Vaccine Product Offered
Table 58. GSK Main Business
Table 59. GSK Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. GSK Latest Developments
Table 61. Tiantan Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 62. Tiantan Gene Engineered Subunit Vaccine Product Offered
Table 63. Tiantan Main Business
Table 64. Tiantan Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Tiantan Latest Developments
Table 66. Pulike Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 67. Pulike Gene Engineered Subunit Vaccine Product Offered
Table 68. Pulike Main Business
Table 69. Pulike Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Pulike Latest Developments
Table 71. Greffex Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 72. Greffex Gene Engineered Subunit Vaccine Product Offered
Table 73. Greffex Main Business
Table 74. Greffex Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Greffex Latest Developments
Table 76. CureVac Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 77. CureVac Gene Engineered Subunit Vaccine Product Offered
Table 78. CureVac Main Business
Table 79. CureVac Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. CureVac Latest Developments
Table 81. Yebio Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 82. Yebio Gene Engineered Subunit Vaccine Product Offered
Table 83. Yebio Main Business
Table 84. Yebio Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Yebio Latest Developments
Table 86. Sanofi Pasteur SA Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 87. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product Offered
Table 88. Sanofi Pasteur SA Main Business
Table 89. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Sanofi Pasteur SA Latest Developments
Table 91. Virbac Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 92. Virbac Gene Engineered Subunit Vaccine Product Offered
Table 93. Virbac Main Business
Table 94. Virbac Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Virbac Latest Developments
Table 96. Pfizer Inc. Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 97. Pfizer Inc. Gene Engineered Subunit Vaccine Product Offered
Table 98. Pfizer Inc. Main Business
Table 99. Pfizer Inc. Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Pfizer Inc. Latest Developments
Table 101. Walvax Biotechnology Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 102. Walvax Biotechnology Gene Engineered Subunit Vaccine Product Offered
Table 103. Walvax Biotechnology Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Walvax Biotechnology Main Business
Table 105. Walvax Biotechnology Latest Developments
Table 106. Kontec Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 107. Kontec Gene Engineered Subunit Vaccine Product Offered
Table 108. Kontec Main Business
Table 109. Kontec Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Kontec Latest Developments
Table 1. Gene Engineered Subunit Vaccine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Therapeutic Gene Engineered Subunit Vaccine
Table 3. Major Players of Preventative Gene Engineered Subunit Vaccine
Table 4. Gene Engineered Subunit Vaccine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene Engineered Subunit Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
Table 7. Gene Engineered Subunit Vaccine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene Engineered Subunit Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
Table 10. Global Gene Engineered Subunit Vaccine Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene Engineered Subunit Vaccine Revenue Market Share by Player (2018-2023)
Table 12. Gene Engineered Subunit Vaccine Key Players Head office and Products Offered
Table 13. Gene Engineered Subunit Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene Engineered Subunit Vaccine Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene Engineered Subunit Vaccine Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene Engineered Subunit Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene Engineered Subunit Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene Engineered Subunit Vaccine Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene Engineered Subunit Vaccine Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene Engineered Subunit Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene Engineered Subunit Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene Engineered Subunit Vaccine Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene Engineered Subunit Vaccine Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene Engineered Subunit Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene Engineered Subunit Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene Engineered Subunit Vaccine Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene Engineered Subunit Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene Engineered Subunit Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene Engineered Subunit Vaccine Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene Engineered Subunit Vaccine
Table 45. Key Market Challenges & Risks of Gene Engineered Subunit Vaccine
Table 46. Key Industry Trends of Gene Engineered Subunit Vaccine
Table 47. Global Gene Engineered Subunit Vaccine Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene Engineered Subunit Vaccine Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene Engineered Subunit Vaccine Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene Engineered Subunit Vaccine Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Merck Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 52. Merck Gene Engineered Subunit Vaccine Product Offered
Table 53. Merck Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Merck Main Business
Table 55. Merck Latest Developments
Table 56. GSK Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 57. GSK Gene Engineered Subunit Vaccine Product Offered
Table 58. GSK Main Business
Table 59. GSK Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. GSK Latest Developments
Table 61. Tiantan Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 62. Tiantan Gene Engineered Subunit Vaccine Product Offered
Table 63. Tiantan Main Business
Table 64. Tiantan Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Tiantan Latest Developments
Table 66. Pulike Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 67. Pulike Gene Engineered Subunit Vaccine Product Offered
Table 68. Pulike Main Business
Table 69. Pulike Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Pulike Latest Developments
Table 71. Greffex Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 72. Greffex Gene Engineered Subunit Vaccine Product Offered
Table 73. Greffex Main Business
Table 74. Greffex Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Greffex Latest Developments
Table 76. CureVac Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 77. CureVac Gene Engineered Subunit Vaccine Product Offered
Table 78. CureVac Main Business
Table 79. CureVac Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. CureVac Latest Developments
Table 81. Yebio Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 82. Yebio Gene Engineered Subunit Vaccine Product Offered
Table 83. Yebio Main Business
Table 84. Yebio Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Yebio Latest Developments
Table 86. Sanofi Pasteur SA Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 87. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product Offered
Table 88. Sanofi Pasteur SA Main Business
Table 89. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Sanofi Pasteur SA Latest Developments
Table 91. Virbac Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 92. Virbac Gene Engineered Subunit Vaccine Product Offered
Table 93. Virbac Main Business
Table 94. Virbac Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Virbac Latest Developments
Table 96. Pfizer Inc. Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 97. Pfizer Inc. Gene Engineered Subunit Vaccine Product Offered
Table 98. Pfizer Inc. Main Business
Table 99. Pfizer Inc. Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Pfizer Inc. Latest Developments
Table 101. Walvax Biotechnology Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 102. Walvax Biotechnology Gene Engineered Subunit Vaccine Product Offered
Table 103. Walvax Biotechnology Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Walvax Biotechnology Main Business
Table 105. Walvax Biotechnology Latest Developments
Table 106. Kontec Details, Company Type, Gene Engineered Subunit Vaccine Area Served and Its Competitors
Table 107. Kontec Gene Engineered Subunit Vaccine Product Offered
Table 108. Kontec Main Business
Table 109. Kontec Gene Engineered Subunit Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Kontec Latest Developments
LIST OF FIGURES
Figure 1. Gene Engineered Subunit Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Engineered Subunit Vaccine Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene Engineered Subunit Vaccine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene Engineered Subunit Vaccine Sales Market Share by Country/Region (2022)
Figure 8. Gene Engineered Subunit Vaccine Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene Engineered Subunit Vaccine Market Size Market Share by Type in 2022
Figure 10. Gene Engineered Subunit Vaccine in Human Use
Figure 11. Global Gene Engineered Subunit Vaccine Market: Human Use (2018-2023) & ($ Millions)
Figure 12. Gene Engineered Subunit Vaccine in Veterinary Use
Figure 13. Global Gene Engineered Subunit Vaccine Market: Veterinary Use (2018-2023) & ($ Millions)
Figure 14. Global Gene Engineered Subunit Vaccine Market Size Market Share by Application in 2022
Figure 15. Global Gene Engineered Subunit Vaccine Revenue Market Share by Player in 2022
Figure 16. Global Gene Engineered Subunit Vaccine Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Gene Engineered Subunit Vaccine Market Size 2018-2023 ($ Millions)
Figure 18. APAC Gene Engineered Subunit Vaccine Market Size 2018-2023 ($ Millions)
Figure 19. Europe Gene Engineered Subunit Vaccine Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Gene Engineered Subunit Vaccine Market Size 2018-2023 ($ Millions)
Figure 21. Americas Gene Engineered Subunit Vaccine Value Market Share by Country in 2022
Figure 22. United States Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Gene Engineered Subunit Vaccine Market Size Market Share by Region in 2022
Figure 27. APAC Gene Engineered Subunit Vaccine Market Size Market Share by Type in 2022
Figure 28. APAC Gene Engineered Subunit Vaccine Market Size Market Share by Application in 2022
Figure 29. China Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Country in 2022
Figure 36. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
Figure 37. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
Figure 38. Germany Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Gene Engineered Subunit Vaccine Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 52. APAC Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 53. Europe Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 55. United States Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 56. Canada Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 59. China Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 60. Japan Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 61. Korea Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 63. India Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 64. Australia Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 65. Germany Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 66. France Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 67. UK Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 68. Italy Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 69. Russia Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 70. Spain Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 73. Israel Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 76. Global Gene Engineered Subunit Vaccine Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Gene Engineered Subunit Vaccine Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Gene Engineered Subunit Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Engineered Subunit Vaccine Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene Engineered Subunit Vaccine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene Engineered Subunit Vaccine Sales Market Share by Country/Region (2022)
Figure 8. Gene Engineered Subunit Vaccine Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene Engineered Subunit Vaccine Market Size Market Share by Type in 2022
Figure 10. Gene Engineered Subunit Vaccine in Human Use
Figure 11. Global Gene Engineered Subunit Vaccine Market: Human Use (2018-2023) & ($ Millions)
Figure 12. Gene Engineered Subunit Vaccine in Veterinary Use
Figure 13. Global Gene Engineered Subunit Vaccine Market: Veterinary Use (2018-2023) & ($ Millions)
Figure 14. Global Gene Engineered Subunit Vaccine Market Size Market Share by Application in 2022
Figure 15. Global Gene Engineered Subunit Vaccine Revenue Market Share by Player in 2022
Figure 16. Global Gene Engineered Subunit Vaccine Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Gene Engineered Subunit Vaccine Market Size 2018-2023 ($ Millions)
Figure 18. APAC Gene Engineered Subunit Vaccine Market Size 2018-2023 ($ Millions)
Figure 19. Europe Gene Engineered Subunit Vaccine Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Gene Engineered Subunit Vaccine Market Size 2018-2023 ($ Millions)
Figure 21. Americas Gene Engineered Subunit Vaccine Value Market Share by Country in 2022
Figure 22. United States Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Gene Engineered Subunit Vaccine Market Size Market Share by Region in 2022
Figure 27. APAC Gene Engineered Subunit Vaccine Market Size Market Share by Type in 2022
Figure 28. APAC Gene Engineered Subunit Vaccine Market Size Market Share by Application in 2022
Figure 29. China Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Country in 2022
Figure 36. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
Figure 37. Europe Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
Figure 38. Germany Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Gene Engineered Subunit Vaccine Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Gene Engineered Subunit Vaccine Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Gene Engineered Subunit Vaccine Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Gene Engineered Subunit Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 52. APAC Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 53. Europe Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 55. United States Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 56. Canada Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 59. China Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 60. Japan Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 61. Korea Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 63. India Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 64. Australia Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 65. Germany Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 66. France Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 67. UK Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 68. Italy Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 69. Russia Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 70. Spain Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 73. Israel Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Gene Engineered Subunit Vaccine Market Size 2024-2029 ($ Millions)
Figure 76. Global Gene Engineered Subunit Vaccine Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Gene Engineered Subunit Vaccine Market Size Market Share Forecast by Application (2024-2029)
